COVID-19 in ocrelizumab-treated people with multiple sclerosis.

Mult Scler Relat Disord · 2021 · PMC7772086 · PMID 33482590

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

For post-marketing cases, despite the extent of missing EDSS data (n=265, 86.3%), a positive trend for more severe outcomes with higher EDSS was noted ( Table A.6 ) .

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.